Citadel Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $229M | Sell |
1,796,100
-1,824,800
| -50% | -$228M | 0.16% | 395 |
|
|
2025
Q4 | $441M | Buy |
3,620,900
+809,800
| +29% | +$92.8M | 0.3% | 222 |
|
|
2025
Q3 | $282M | Buy |
2,811,100
+518,400
| +23% | +$46.7M | 0.23% | 353 |
|
|
2025
Q2 | $190M | Sell |
2,292,700
-131,300
| -5% | -$10.5M | 0.16% | 428 |
|
|
2025
Q1 | $197M | Sell |
2,424,000
-958,900
| -28% | -$85.7M | 0.19% | 379 |
|
|
2024
Q4 | $305M | Sell |
3,382,900
-217,000
| -6% | -$21M | 0.28% | 257 |
|
|
2024
Q3 | $356M | Sell |
3,599,900
-113,600
| -3% | -$11.2M | 0.37% | 202 |
|
|
2024
Q2 | $344M | Sell |
3,713,500
-2,255,600
| -38% | -$202M | 0.34% | 200 |
|
|
2024
Q1 | $566M | Buy |
5,969,100
+886,100
| +17% | +$82.2M | 0.55% | 115 |
|
|
2023
Q4 | $454M | Buy |
5,083,000
+2,556,200
| +101% | +$190M | 0.46% | 127 |
|
|
2023
Q3 | $185M | Buy |
2,526,800
+160,000
| +7% | +$12.8M | 0.2% | 345 |
|
|
2023
Q2 | $197M | Buy |
2,366,800
+93,200
| +4% | +$7.79M | 0.22% | 334 |
|
|
2023
Q1 | $173M | Sell |
2,273,600
-182,800
| -7% | -$15.2M | 0.19% | 378 |
|
|
2022
Q4 | $204M | Sell |
2,456,400
-1,231,100
| -33% | -$99.7M | 0.24% | 331 |
|
|
2022
Q3 | $292M | Buy |
3,687,500
+568,500
| +18% | +$47.9M | 0.36% | 189 |
|
|
2022
Q2 | $232M | Buy |
3,119,000
+47,800
| +2% | +$3.59M | 0.32% | 238 |
|
|
2022
Q1 | $276M | Buy |
3,071,200
+942,300
| +44% | +$87M | 0.32% | 233 |
|
|
2021
Q4 | $238M | Buy |
2,128,900
+68,200
| +3% | +$8.23M | 0.26% | 290 |
|
|
2021
Q3 | $259M | Buy |
2,060,700
+890,800
| +76% | +$115M | 0.29% | 257 |
|
|
2021
Q2 | $158M | Buy |
1,169,900
+222,200
| +23% | +$29.2M | 0.16% | 428 |
|
|
2021
Q1 | $129M | Sell |
947,700
-1,675,300
| -64% | -$251M | 0.14% | 471 |
|
|
2020
Q4 | $369M | Buy |
2,623,000
+407,400
| +18% | +$52.2M | 0.41% | 122 |
|
|
2020
Q3 | $247M | Sell |
2,215,600
-655,800
| -23% | -$73.5M | 0.33% | 150 |
|
|
2020
Q2 | $321M | Buy |
2,871,400
+902,600
| +46% | +$88.9M | 0.44% | 88 |
|
|
2020
Q1 | $152M | Sell |
1,968,800
-1,847,200
| -48% | -$164M | 0.23% | 200 |
|
|
2019
Q4 | $363M | Buy |
3,816,000
+1,080,800
| +40% | +$93.5M | 0.44% | 74 |
|
|
2019
Q3 | $209M | Buy |
2,735,200
+760,000
| +38% | +$63.2M | 0.26% | 149 |
|
|
2019
Q2 | $173M | Sell |
1,975,200
-1,383,400
| -41% | -$118M | 0.21% | 204 |
|
|
2019
Q1 | $304M | Buy |
3,358,600
+1,447,800
| +76% | +$123M | 0.41% | 73 |
|
|
2018
Q4 | $137M | Buy |
1,910,800
+658,000
| +53% | +$53M | 0.21% | 224 |
|
|
2018
Q3 | $120M | Sell |
1,252,800
-493,300
| -28% | -$47.8M | 0.14% | 349 |
|
|
2018
Q2 | $166M | Buy |
1,746,100
+413,300
| +31% | +$38M | 0.22% | 205 |
|
|
2018
Q1 | $117M | Buy |
1,332,800
+66,300
| +5% | +$6.05M | 0.18% | 268 |
|
|
2017
Q4 | $107M | Buy |
1,266,500
+498,100
| +65% | +$41.7M | 0.14% | 306 |
|
|
2017
Q3 | $66.5M | Sell |
768,400
-17,500
| -2% | -$1.4M | 0.11% | 410 |
|
|
2017
Q2 | $60.7M | Buy |
785,900
+112,900
| +17% | +$8.01M | 0.11% | 405 |
|
|
2017
Q1 | $46.7M | Sell |
673,000
-605,600
| -47% | -$40.7M | 0.08% | 492 |
|
|
2016
Q4 | $75.7M | Buy |
1,278,600
+647,800
| +103% | +$40M | 0.17% | 238 |
|
|
2016
Q3 | $41.8M | Buy |
+630,800
| New | +$39M | 0.09% | 473 |
|
Other funds holding XBI
